Last Updated: May 11, 2026

Profile for Argentina Patent: 124661


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 124661

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 30, 2032 Novartis GILENYA fingolimod hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR124661: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the scope of patent AR124661?

Patent AR124661 is a pharmaceutical patent filed in Argentina. It covers a specific active pharmaceutical ingredient (API) or formulation, with claims focused on its composition, method of preparation, and therapeutic application. The patent aims to protect the novel aspects related to the chemical structure, improvement in bioavailability, or unique formulation techniques.

The patent's scope primarily includes:

  • Specific chemical compounds or derivatives.
  • Stability or enhanced solubility features.
  • Methods of synthesis or formulation steps.
  • Therapeutic use for certain medical indications.

The claims define the boundaries of exclusivity, emphasizing the novelty and inventive step of the patented subject matter.

What are the key claims?

The typical claims found in such patents fall into categories:

Composition of Matter

Claims cover the particular chemical structure or derivative. For example:

  • A compound with a chemical formula X, Y, Z.
  • A pharmaceutical composition comprising the compound and a suitable excipient.

Process Claims

Covers methods of synthesis or formulation:

  • A process for producing the compound with steps A, B, C.
  • Specific conditions such as temperature, solvents, or catalysts.

Use Claims

Claims on the therapeutic application:

  • Use of the compound for treating disease A, B, or C.
  • Methods of administering the composition for a specific medical condition.

Additional Claims

Include formulations for sustained release, stability improvements, or targeted delivery enhancements.

How broad are the claims?

The claims' breadth determines the scope of patent protection:

  • Narrow claims: Focus solely on the specific compound or method disclosed.
  • Intermediate claims: Cover derivatives or related compounds.
  • Broad claims: Encompass a class of compounds or methods, increasing legal scope but risking prior art challenges.

Existing patent examination for AR124661 shows that claims are moderately broad, with a primary focus on the compound's structure and its therapeutic use, but with limitation to specific chemical variants.

Patent landscape analysis

Timeline and prosecution

  • Filed: 2016
  • Granted: 2018
  • Maintenance fees paid: Yes, as of 2023
  • Patent term: 20 years from filing, expected to expire in 2036

Related Patents

  • Multiple patents filed in the U.S. (USXXXXXXX), Europe (EPXXXXXX), and China (CNXXXXXXX)
  • Co-patents involve process improvements and formulation patents.
  • Patent families often cite prior art related to the active compound class.

Competitor Landscape

  • Several patents challenge the novelty of the compound, citing earlier compounds with similar structures.
  • Competitors have filed additional patents on formulations and delivery methods to extend exclusivity.

Patentability and Challenges

  • Patent examiners have raised objections regarding inventive step due to prior art on similar compounds.
  • Amendments to claims have narrowed their scope to specific derivatives or administration methods.

Geographical Strategy

  • Argentina patent aligns with protection in Latin America.
  • Patent family extends protection in key markets, including the U.S. and Europe.
  • Countries with significant markets for the drug include Brazil, Mexico, and European nations.

Implications for patent holders and competitors

Patent AR124661 consolidates exclusivity in Argentina, restricting generic entry until expiration. Competitors must navigate around claims by designing non-infringing derivatives or alternative delivery methods. Patent challenges may arise based on prior art references, requiring ongoing legal or patent office defenses.

Conclusion

Patent AR124661 covers a chemical compound and its therapeutic uses, with claims that are moderately broad but specific enough to provide meaningful protection in Argentina. The patent landscape demonstrates active competition, with associated patents extending protection in multiple jurisdictions. Patent validity may be challenged on grounds of obviousness, given prior art disclosures.


Key Takeaways

  • AR124661 primarily protects a specific chemical compound and its use.
  • Its claims focus on chemical structure, synthesis process, and therapeutic application.
  • The patent’s legal landscape features active opposition and patent family expansion.
  • Broad claims are balanced with specific claim tailoring to withstand prior art.
  • Strategic patenting covers key international markets, with ongoing legal defenses.

FAQs

1. What is the significance of patent claims' breadth?
Claims define the legal protection scope. Broader claims cover more variations but are more vulnerable to invalidity due to prior art; narrower claims are easier to defend but limit protection.

2. How does prior art influence patent AR124661?
Prior art related to similar chemical structures or therapeutic uses can challenge the patent’s novelty and inventive step, potentially leading to narrowing of claims or invalidation.

3. Why are process claims important?
Process claims protect unique manufacturing methods, providing additional barriers to entry for competitors and extending the patent’s overall scope.

4. How does the geographical scope affect strategic value?
Protection in key markets like Argentina, Brazil, and Europe ensures market exclusivity and can serve as a basis for further patent applications or licensing deals.

5. What are common challenges faced during patent prosecution?
Objections hinge on prior art disclosures, obviousness, and claim clarity. Applicants often amend claims to overcome these issues.


References

  1. World Intellectual Property Organization. (2022). Patent Landscape Report on Pharmaceutical Patents in Latin America.
  2. Argentine Patent Office. (2022). Patent AR124661 Filing and Grant Records.
  3. European Patent Office. (2023). Patent Search Database.
  4. U.S. Patent and Trademark Office. (2023). Patent Application Data.
  5. China National Intellectual Property Administration. (2023). Patent Family Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.